Exploring Large Language Models for Specialist-Level Oncology Care
Anil Palepu, Vikram Dhillon, Polly Niravath, Wei‐Hung Weng et autres
us (code pays fourni par la source)
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
Anil Palepu, Vikram Dhillon, Polly Niravath, Wei‐Hung Weng et autres
us (code pays fourni par la source)
Zainub Ajmal, Jian Guan, Jitesh Joshi, Eric Bernicker et autres
8551 Background: Interleukin-12 (IL-12) is a cytokine that enhances anti-tumor immunity via interferon-gamma release and has demonstrated synergistic effects with immune checkpoint inhibitors (ICIs) in immunoquiescent tumors. We report results of phase I trial of intratumoral adenovirus-interleukin-12(IT-ADV/IL-12)plus atezolizumab in metastatic NSCLC patients …
us (code pays fourni par la source)
Anil Palepu, Vikram Dhillon, Polly Niravath, Wei‐Hung Weng et autres
Large language models (LLMs) have shown remarkable progress in encoding clinical knowledge and responding to complex medical queries with appropriate clinical reasoning. However, their applicability in subspecialist or complex medical settings remains underexplored. In this work, we probe the performance of AMIE, …
Nikitha Vobugari, Kirk Heyne, Ashton A. Connor, Zainub Ajmal et autres
11173 Background: Increasing liver transplantation (LT) utilization has resulted in more and more patients with a history of a non-hepatobiliary malignancy. Rather than deny such patients a lifesaving therapy the benefits must be weighed against risk of tumor recurrence and de novo …
us (code pays fourni par la source)
Zainub Ajmal, Jianming Shao, Randall J. Olsen, Saro Kasparian et autres
e20563 Background: Immune checkpoint inhibitors (ICIs) targeting programmed cell death 1 (PD-1), and its ligand (PD-L1) are the mainstay of treatment for metastatic non-small cell lung cancer (NSCLC) in patients lacking targetable driver mutations. However, optimal predictive biomarkers are lacking. We used …
us (code pays fourni par la source)
Jian Guan, Shubham Adroja, Zainub Ajmal, Yuan Gao et autres
85 Background: Relugolix is the first oral GNRH antagonist approved by the FDA in 2021 for the treatment of advanced prostate cancer (PCa). Approval was based on HERO study, which showed a rapid and sustained testosterone suppression superior to that of Leuprolide …
us (code pays fourni par la source)
Ryan Blair Kieser, Ethan Burns, Zimu Gong, Jian Guan et autres
e20531 Background: One-third of patients with newly diagnosed non-small cell lung cancer (NSCLC) present at an early stage. Surgical resection remains the standard of care for medically fit patients. Adjuvant chemotherapy has shown benefit in stage II and III disease, but with …
us (code pays fourni par la source)
Journal of the American College of Surgeons ():10.1097/XCS.0000000000000760, May 15, 2023. | DOI: 10.1097/XCS.0000000000000760
us (code pays fourni par la source)
Amin Azem, Zainub Ajmal, Mihir Raval
Allogeneic hematopoietic stem cell transplant (AHSCT) recipients are at a risk of developing immune-mediated tissue damage from activation of the donor's immunocompetent T cells by the recipient's normally expressed antigens, a phenomenon called graft-versus-host disease (GVHD). With the emergence of the novel …
us (code pays fourni par la source)
Background: Penile leiomyosarcoma arises from smooth muscles, which can be from dartos fascia, erector pili in the skin covering the shaft, or from tunica media of the superficial vessels and cavernosa. We describe presentation, treatment options, and recurrence pattern of this rare …
us (code pays fourni par la source)
Fatima Tuz Zahra, Zainub Ajmal, Sana Ghalib, Boris Shkolnik
Fatima Tuz Zahra, Zainub Ajmal, Gowthami Kobbari, Gregory F. Wu
BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.
L'essentiel de l'actu tech du Burkina & d'Afrique, chaque semaine dans votre boîte mail.
Gratuit · sans spam · désinscription en un clic